DR. SETH DAVID ROSEN MD NPI 1740398262

NPI Information

  • NPI: 1740398262
  • Provider Name: DR. SETH DAVID ROSEN, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1871 SE TIFFANY AVE
    SUITE 100
    PORT ST LUCIE, FL
    ZIP 34952
  • Phone: (772) 924-2283

Map and Directions

Get Directions

NPI Details

DR. Seth David Rosen, MD is a hematology and oncology internal medicine in Port St Lucie, FL with 26 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Seth David Rosen, MD NPI is 1740398262. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WARREN ALPERT MEDICAL SCHOOL OF BROWN UNIVERSITY
Graduation Year:2000

The provider's business location address is:

1871 SE TIFFANY AVE
SUITE 100
PORT ST LUCIE, FL
ZIP 34952-596
Phone: (772) 924-2283
Fax: (772) 924-2282

The NPI 1740398262 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Magnesium level (HCPCS:83735)
  • Folic acid level, serum (HCPCS:82746)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Blood test, clotting time (HCPCS:85610)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Anticoagulant management of patient taking warfarin (HCPCS:93793)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Blood creatinine level (HCPCS:82565)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Uric acid level, blood (HCPCS:84550)
  • Injection, lorazepam, 2 mg (HCPCS:J2060)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Stool analysis for blood, by peroxidase activity (HCPCS:82272)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Injection of drug or substance into vein (HCPCS:96374)

The enumeration date for this NPI number is 8/25/2006 and was last updated on 6/2/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyME109318FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.